N Novonesis (Novozymes) B
N
Open
367.7 0.14
Overzicht
Wijziging aandelenprijs
24u
Min
365.9
Max
369.8
Inkomsten | 76M 199M |
|---|---|
Verkoop | 123M 1.1B |
K/W Sectorgemiddelde | 39.155 37.623 |
EPS | 4.258 |
Dividendrendement | 0.23 |
Winstmarge | 17.788 |
Werknemers | 10,933 |
EBITDA | 151M 268M |
Dividendrendement Sectorgemiddelde | 0.23% 2.53% |
|---|
Marktkapitalisatie | -11B 175B |
|---|---|
Vorige openingsprijs | 367.56 |
Vorige sluitingsprijs | 367.7 |
Novonesis (Novozymes) B Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Novonesis (Novozymes) B Prognose
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Novonesis (Novozymes) B
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
